Options markets are flashing notable signals across several names today. Analysts and traders appear to be repositioning ahead of key June expiries.
ILMN grabbed attention after Guggenheim raised its price target to $180. The genomics giant carries just 5.1% SI % of FF. Its options structure is notably thin, with only two active expiries — June 18 and July 17. That limited expiry ladder suggests traders are concentrating bets into a tight window around any catalyst.
FATE is a smaller but sharper signal. The biotech presented CAR T-cell data at ASCO on June 1. Three expiries are live — June 18, July 17, and August 21. With 10.8% SI % of FF and a cost to borrow of 0.79%, this is a name where call buyers could squeeze shorts hard if the ASCO data lands well.
MSTR shows the most complex expiry structure of the group — 12 separate dates running through August 21. Short interest sits at 11.9% of free float. Availability is 230%, meaning borrow is still accessible. The dense near-term expiry ladder — including June 5, June 11, and June 12 — points to active short-term speculation tied to Bitcoin price moves.
TSLA momentum scores rose steadily through May, reaching 57.7 on June 1 from 48.8 in early May. Its 25 active expiry dates reflect deep two-sided positioning. holds the broadest expiry structure with dates stretching to September 2. Both names remain arenas for directional options flow.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
